Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 4 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Ventyx Biosciences Inc have a median target of 10.00, with a high estimate of 21.00 and a low estimate of 2.00. The median estimate represents a 440.54% increase from the last price of 1.85.
High | 1,035.1% | 21.00 |
Med | 440.5% | 10.00 |
Low | 8.1% | 2.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 24, 2025.
Average growth rate | +12.99% |
Average growth rate | +4.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼